The fructose metabolism, mediated by GLUT5, supports pancreatic ductal adenocarcinoma (PDAC) progression by enhancing cell survival, proliferation, and metabolic plasticity, while inhibiting autophagic cell death through the AMPK-mTORC1 pathway. The gene discussed is SLC2A5; the disease is pancreatic ductal adenocarcinoma.